President Biden Signs Historic Cannabis Research Bill – Ganjapreneur
President Biden's signing of historic cannabis research legislation removes federal barriers that have restricted scientific investigation of cannabis for decades. This bill enables researchers to conduct more rigorous clinical trials and epidemiological…
Ibogaine Psychiatric Research 2026: Latest Clinical Insights
This article digest highlights ibogaine psychiatric research 2026 and its intersection with cannabis regulatory developments. It reviews recent clinical insights and policy changes relevant to cannabinoid medicine. The focus on ibogaine psychiatric…
Tilray CEO Discusses US Cannabis Reclassification and Market Outlook
The US cannabis reclassification could ease federal restrictions and open new research opportunities. Tilray's CEO highlights potential market expansion tied to these regulatory changes. This shift may facilitate clinical evidence development and broader…
SC hemp ban back on table. Four options left for future of THC edibles – The State
South Carolina hemp regulations are being reconsidered with four policy options for the future of THC edibles. This evolving legal landscape affects the status of hemp-derived THC products. Patients and clinicians face uncertainty in product legality and…
Impact of Florida Medical Cannabis Smokable Flower on THC Dispensing
Florida medical cannabis smokable flower legalization led to a sharp rise in THC dispensed per patient. This study quantifies the increase in weekly THC amounts following the 2019 policy change. Understanding these trends is crucial for clinicians and…
Congress Floats Plan to Let States Opt Out of Federal Hemp THC Ban
The state hemp THC regulation opt-out plan could create varied patient access to cannabinoid products. Clinicians must understand these regulatory changes to guide patients effectively. This plan may lead to inconsistent product standards across states.
New Bill Could Expand Access to Hemp-Derived Cannabinoid Products
The new legislation aims to expand hemp-derived cannabinoid products access by allowing states to set their own THC limits. This change could improve patient availability but complicates clinical counseling due to variable product standards. Clinicians…
Marijuana Use Linked to Heart Attacks and Strokes in New Study
The 2026 cannabis cardiovascular risks study reveals links between marijuana use and increased heart attack and stroke incidents. Clinicians should consider these risks when assessing patients. Understanding cannabis cardiovascular effects is crucial for…
Hemp vs Weed? NJ Adjusts THC Rules Just Before 4/20. What to Know
NJ hemp THC rules 2026 introduce higher THC limits in hemp products, affecting clinical guidance on cannabis use. These changes create challenges in product labeling and potency consistency. Clinicians must understand NJ hemp THC rules 2026 to advise…
Cannabis Sales and Use Are High in Michigan – But Federal Law Means Research Lags Behind
Cannabis research barriers Michigan faces create challenges for clinicians advising patients. Federal restrictions limit clinical research despite high cannabis use. This gap impacts evidence-based guidance and patient safety.
